Ovintiv (NYSE:OVV) Stock Price Expected to Rise, Barclays Analyst Says

Ovintiv (NYSE:OVVGet Free Report) had its price target lifted by analysts at Barclays from $55.00 to $58.00 in a report released on Wednesday, Marketbeat reports. The firm presently has an “overweight” rating on the stock. Barclays‘s price target would suggest a potential upside of 17.31% from the stock’s current price.

Several other research firms also recently commented on OVV. National Bank Financial lifted their price objective on Ovintiv from $54.00 to $56.00 and gave the stock an “outperform” rating in a report on Tuesday, February 3rd. TD Cowen raised shares of Ovintiv to a “strong-buy” rating in a report on Monday, February 9th. Stephens raised shares of Ovintiv to a “hold” rating in a report on Tuesday, February 3rd. Evercore restated an “outperform” rating and set a $47.00 price objective on shares of Ovintiv in a research report on Thursday, November 6th. Finally, Jefferies Financial Group reaffirmed a “buy” rating and issued a $54.00 target price on shares of Ovintiv in a research report on Saturday, January 17th. Two equities research analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $52.72.

View Our Latest Research Report on OVV

Ovintiv Price Performance

Shares of NYSE OVV opened at $49.44 on Wednesday. The firm has a market cap of $14.01 billion, a P/E ratio of 10.21, a PEG ratio of 2.82 and a beta of 0.78. Ovintiv has a twelve month low of $29.80 and a twelve month high of $51.60. The company has a quick ratio of 0.45, a current ratio of 0.54 and a debt-to-equity ratio of 0.39. The company has a 50 day moving average of $42.61 and a 200 day moving average of $40.75.

Ovintiv (NYSE:OVVGet Free Report) last posted its earnings results on Monday, February 23rd. The company reported $1.39 EPS for the quarter, topping analysts’ consensus estimates of $0.98 by $0.41. Ovintiv had a return on equity of 12.00% and a net margin of 13.94%.The business had revenue of $1.89 billion during the quarter, compared to analyst estimates of $1.89 billion. During the same quarter last year, the company earned ($0.23) EPS. As a group, research analysts expect that Ovintiv will post 5.59 EPS for the current fiscal year.

Insider Transactions at Ovintiv

In other Ovintiv news, COO Gregory Dean Givens sold 50,000 shares of the company’s stock in a transaction that occurred on Friday, December 12th. The shares were sold at an average price of $40.33, for a total transaction of $2,016,500.00. Following the completion of the sale, the chief operating officer directly owned 105,867 shares of the company’s stock, valued at approximately $4,269,616.11. This represents a 32.08% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 1.70% of the company’s stock.

Institutional Investors Weigh In On Ovintiv

A number of hedge funds have recently modified their holdings of the business. McIlrath & Eck LLC purchased a new stake in shares of Ovintiv in the 3rd quarter worth $31,000. HM Payson & Co. bought a new stake in Ovintiv during the third quarter valued at about $36,000. Foster Dykema Cabot & Partners LLC bought a new stake in Ovintiv during the third quarter valued at about $36,000. Quent Capital LLC purchased a new stake in Ovintiv in the third quarter worth about $37,000. Finally, Flagship Harbor Advisors LLC bought a new position in shares of Ovintiv in the fourth quarter worth about $38,000. Institutional investors own 83.81% of the company’s stock.

Ovintiv News Summary

Here are the key news stories impacting Ovintiv this week:

  • Positive Sentiment: Q4 earnings beat consensus and helped push OVV to a 12-month high — the company topped EPS estimates and production rose, supporting earnings momentum and investor confidence. Ovintiv (NYSE:OVV) Hits New 12-Month High on Better-Than-Expected Earnings
  • Positive Sentiment: Multiple major firms raised price targets and ratings this week (UBS, Barclays, National Bank Financial, JPMorgan), signaling stronger analyst conviction and adding buying pressure from fund and model-driven investors. Analyst Coverage/Price Target Moves
  • Positive Sentiment: Short interest fell sharply (down ~36% month-over-month to ~10.2M shares), lowering potential short-squeeze risk and removing some selling pressure from the stock. This reduction in shorts can mechanically support higher prices given OVV’s trading volume. (No external link)
  • Neutral Sentiment: Zacks reports the Q4 beat was accompanied by year-over-year revenue decline tied to weaker oil prices — a mixed result that underscores earnings strength but also exposure to commodity price swings. Ovintiv Q4 Earnings Surpass Estimates, Revenues Decline Y/Y
  • Neutral Sentiment: A comparative piece on Seeking Alpha discusses Ovintiv versus a peer, offering investor viewpoints that could attract interest but are opinion-based rather than news-driven. Ovintiv Vs. Paramount Resources: Why It’s Time To Buy One And Sell The Other

About Ovintiv

(Get Free Report)

Ovintiv Inc is a North American energy company focused on the exploration, development and production of oil, natural gas and natural gas liquids. Formerly known as Encana Corporation, the company rebranded as Ovintiv in January 2020 and established its headquarters in Denver, Colorado. Ovintiv’s upstream portfolio spans multiple unconventional resource plays, reflecting a strategy centered on high-return projects and disciplined capital allocation.

The company’s core business activities include the acquisition and development of acreage in major shale basins across the United States and Canada.

Featured Stories

Analyst Recommendations for Ovintiv (NYSE:OVV)

Receive News & Ratings for Ovintiv Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ovintiv and related companies with MarketBeat.com's FREE daily email newsletter.